investors Archives -

Activist investors are pushing back against Merck & Co’s recent $11.5 billion deal to acquire Acceleron Pharma, arguing

Acceleron investors dig their heels in on Merck takeover bid

https://pharmaphorum.com/news/acceleron-investors-dig-their-heels-in-on-merck-takeover-bid/

Activist hedge fund Bluebell Capital Partners has joined Elliott Investment in taking a stake in GlaxoSmithKline and pushing

Second hedge fund applies pressure on GSK after taking stake

https://pharmaphorum.com/news/second-hedge-fund-applies-pressure-on-gsk-after-taking-stake/

The chances of former shareholders in Celgene missing out on the big pay-out from their contingent value right

Celgene investors’ CVR payment looks rocky, as FDA rejects ide-cel file

https://pharmaphorum.com/news/celgene-investors-merger-payment-looks-rocky-as-fda-rejects-ide-cel-file/

Biogen is trying to resurrect two failed trials of its Alzheimer’s drug aducanumab – and superstar investor Warren

Warren Buffet shocks Wall Street with Biogen gamble

https://pharmaphorum.com/news/warren-buffet-shocks-wall-street-with-biogen-gamble/

investors